Citigroup Initiates Coverage On UiPath with Buy Rating, Announces Price Target of $23
Citigroup analyst Yitchuin Wong initiates coverage on UiPath (NYSE:PATH) with a Buy rating and announces Price Target of $23.
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Citigroup analyst Yitchuin Wong initiates coverage on UiPath (NYSE:PATH) with a Buy rating and announces Price Target of $23.
Filed: 2026-09-08 AccNo: 0001326771-26-000145 Size: 456 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Citigroup analyst Ariel Rosa upgrades Old Dominion Freight Line (NASDAQ:ODFL) from Neutral to Buy and lowers the price target from $231 to $223.
Citigroup analyst Ariel Rosa upgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Neutral to Buy and lowers the price target from $196 to $185.
The Guidewire stock drop hit 20% after a Q4 earnings beat. See why soft FY27 guidance and a stretched valuation triggered the sell-off.
Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $108.
Filed: 2026-09-08 AccNo: 0001663577-26-000262 Size: 280 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 4.35% on an annualized basis producing an average annual return of 17.57%. Currently, Thermo Fisher Scientific has a market
Robinhood strikes a multiyear Crypto.com deal to add OG contracts and take minority stakes as its prediction-market business keeps growing.
Shopify (SHOP) fell nearly 8% as investors rotated away from high-multiple growth stocks despite strong Q2 earnings. Learn more.
AstraZeneca secured FDA approval for its breast cancer drug Etcamah and reported positive Phase 3 trial data for lung cancer and COPD.
Oddity Tech shares fall ahead of Q2 results. Needham analyst expects CPA pressure but signs of stabilization.
Visa introduces an onchain credit model combining VisaNet settlement data with blockchain lending to help stablecoin-linked card programs access working capital.
Jabil (NYSE:JBL) has outperformed the market over the past 10 years by 17.45% on an annualized basis producing an average annual return of 31.12%. Currently, Jabil has a market capitalization of $32.69 billion. Buying